Prelude Capital Management’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-112,350
| Closed | -$1.13M | – | 1436 |
|
|
2022
Q4 | $1.13M | Buy |
112,350
+14,450
| +15% | +$145K | 0.06% | 316 |
|
|
2022
Q3 | $961K | Sell |
97,900
-58,016
| -37% | -$569K | 0.03% | 435 |
|
|
2022
Q2 | $1.53M | Buy |
155,916
+2,695
| +2% | +$26.4K | 0.04% | 304 |
|
|
2022
Q1 | $1.5M | Hold |
153,221
| – | – | 0.04% | 352 |
|
|
2021
Q4 | $1.49M | Sell |
153,221
-2,750
| -2% | -$26.8K | 0.04% | 314 |
|
|
2021
Q3 | $1.51M | Buy |
155,971
+2,750
| +2% | +$26.7K | 0.04% | 281 |
|
|
2021
Q2 | $1.49M | Buy |
+153,221
| New | +$1.49M | 0.04% | 312 |
|